• Mashup Score: 0

    Luis Malpica Castillo, MD, The University of Texas MD Anderson Cancer Center, discusses cutaneous T-cell lymphoma (CTCL)  and the challenges of treating people of color.

    Tweet Tweets with this article
    • Luis Malpica Castillo, MD, discusses cutaneous T-cell lymphoma #CTCL and the challenges of treating people of color #checkrare #rarediseases @skinlymphoma https://t.co/C1UJc5lj4L

  • Mashup Score: 1

    Luis Malpica Castillo, MD, The University of Texas MD Anderson Cancer Center, discusses cutaneous T-cell lymphoma (CTCL)  and the challenges of treating people of color.

    Tweet Tweets with this article
    • Luis Malpica Castillo, MD, discusses cutaneous T-cell lymphoma #CTCL and the challenges of treating people of color #checkrare #rarediseases @skinlymphoma https://t.co/C1UJc5lj4L

  • Mashup Score: 1

    Luis Malpica Castillo, MD, The University of Texas MD Anderson Cancer Center, discusses cutaneous T-cell lymphoma (CTCL)  and the challenges of treating people of color.

    Tweet Tweets with this article
    • Luis Malpica Castillo, MD, discusses cutaneous T-cell lymphoma #CTCL and the challenges of treating people of color #checkrare #rarediseases @skinlymphoma https://t.co/C1UJc5lj4L

  • Mashup Score: 0

    Cutaneous T-cell lymphoma (CTCL) belongs to the non-Hodgkin lymphoma class of hematologic T-cell lymphoproliferative disorders.

    Tweet Tweets with this article
    • Check out our learning page on Cutaneous T-Cell Lymphoma #CTCL @skinlymphoma #checkrare #rarediseases #cutaneouslymphoma https://t.co/yBk2J3suJQ

  • Mashup Score: 0

    Luis Malpica Castillo, MD, The University of Texas MD Anderson Cancer Center, discusses cutaneous T-cell lymphoma (CTCL)  and the challenges of treating people of color.

    Tweet Tweets with this article
    • Luis Malpica Castillo, MD, discusses cutaneous T-cell lymphoma #CTCL and the challenges of treating people of color #checkrare #rarediseases @skinlymphoma https://t.co/C1UJc5lj4L